Moderna’s and Pfizer-BioNTech’s updated COVID-19 booster vaccines that target the highly transmittable omicron variant are expected to be ready for rollout in a matter of days after the Centers for Disease Control and Prevention signed off on the updated shots.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.